nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—FMO3—sweat—bipolar disorder	0.0464	0.106	CbGeAlD
Vandetanib—RET—autonomic nervous system—bipolar disorder	0.0168	0.0382	CbGeAlD
Vandetanib—FMO3—urine—bipolar disorder	0.0132	0.0301	CbGeAlD
Vandetanib—LYN—blood plasma—bipolar disorder	0.0104	0.0237	CbGeAlD
Vandetanib—ORM1—saliva—bipolar disorder	0.00991	0.0226	CbGeAlD
Vandetanib—FLT3—blood plasma—bipolar disorder	0.0089	0.0203	CbGeAlD
Vandetanib—FYN—blood plasma—bipolar disorder	0.00665	0.0152	CbGeAlD
Vandetanib—STK10—blood plasma—bipolar disorder	0.00595	0.0136	CbGeAlD
Vandetanib—SRC—blood plasma—bipolar disorder	0.00578	0.0132	CbGeAlD
Vandetanib—KDR—blood plasma—bipolar disorder	0.00531	0.0121	CbGeAlD
Vandetanib—FLT4—adrenal cortex—bipolar disorder	0.0041	0.00935	CbGeAlD
Vandetanib—VEGFA—adrenal cortex—bipolar disorder	0.00407	0.00927	CbGeAlD
Vandetanib—EPHA8—nervous system—bipolar disorder	0.00402	0.00917	CbGeAlD
Vandetanib—IRAK4—adrenal cortex—bipolar disorder	0.00398	0.00908	CbGeAlD
Vandetanib—EPHA8—cerebellum—bipolar disorder	0.00379	0.00863	CbGeAlD
Vandetanib—MKNK1—adrenal cortex—bipolar disorder	0.00367	0.00836	CbGeAlD
Vandetanib—BMPR1B—thyroid gland—bipolar disorder	0.00363	0.00826	CbGeAlD
Vandetanib—AXL—adrenal cortex—bipolar disorder	0.00361	0.00822	CbGeAlD
Vandetanib—FMO3—adrenal cortex—bipolar disorder	0.0035	0.00797	CbGeAlD
Vandetanib—SLK—adrenal cortex—bipolar disorder	0.00347	0.00791	CbGeAlD
Vandetanib—CYP3A4—urine—bipolar disorder	0.00345	0.00786	CbGeAlD
Vandetanib—EPHA6—nervous system—bipolar disorder	0.00336	0.00765	CbGeAlD
Vandetanib—TEK—adrenal cortex—bipolar disorder	0.0033	0.00752	CbGeAlD
Vandetanib—LTK—brain—bipolar disorder	0.00321	0.00731	CbGeAlD
Vandetanib—EPHA5—nervous system—bipolar disorder	0.00311	0.00709	CbGeAlD
Vandetanib—TYRO3—nervous system—bipolar disorder	0.00311	0.00709	CbGeAlD
Vandetanib—LYN—nervous system—bipolar disorder	0.0031	0.00706	CbGeAlD
Vandetanib—STK35—thyroid gland—bipolar disorder	0.00308	0.00703	CbGeAlD
Vandetanib—EPHA8—brain—bipolar disorder	0.00308	0.00701	CbGeAlD
Vandetanib—BMPR1B—nervous system—bipolar disorder	0.00305	0.00695	CbGeAlD
Vandetanib—MAP3K19—nervous system—bipolar disorder	0.00305	0.00695	CbGeAlD
Vandetanib—YES1—adrenal cortex—bipolar disorder	0.00305	0.00694	CbGeAlD
Vandetanib—ABL2—thyroid gland—bipolar disorder	0.003	0.00685	CbGeAlD
Vandetanib—EGFR—thyroid gland—bipolar disorder	0.00293	0.00668	CbGeAlD
Vandetanib—EPHA5—cerebellum—bipolar disorder	0.00293	0.00668	CbGeAlD
Vandetanib—TYRO3—cerebellum—bipolar disorder	0.00293	0.00668	CbGeAlD
Vandetanib—BMPR1B—cerebellum—bipolar disorder	0.00287	0.00654	CbGeAlD
Vandetanib—FLT4—thyroid gland—bipolar disorder	0.00286	0.00651	CbGeAlD
Vandetanib—RIPK2—thyroid gland—bipolar disorder	0.00284	0.00648	CbGeAlD
Vandetanib—VEGFA—thyroid gland—bipolar disorder	0.00283	0.00646	CbGeAlD
Vandetanib—FMO1—thyroid gland—bipolar disorder	0.00282	0.00643	CbGeAlD
Vandetanib—IRAK4—thyroid gland—bipolar disorder	0.00278	0.00633	CbGeAlD
Vandetanib—ERBB3—thyroid gland—bipolar disorder	0.00272	0.0062	CbGeAlD
Vandetanib—KDR—adrenal cortex—bipolar disorder	0.0027	0.00615	CbGeAlD
Vandetanib—MAP2K5—adrenal cortex—bipolar disorder	0.0027	0.00615	CbGeAlD
Vandetanib—STK35—nervous system—bipolar disorder	0.00259	0.00591	CbGeAlD
Vandetanib—EPHA6—brain—bipolar disorder	0.00256	0.00584	CbGeAlD
Vandetanib—MKNK1—thyroid gland—bipolar disorder	0.00255	0.00582	CbGeAlD
Vandetanib—PLK4—brain—bipolar disorder	0.00253	0.00577	CbGeAlD
Vandetanib—FGR—thyroid gland—bipolar disorder	0.00252	0.00575	CbGeAlD
Vandetanib—RET—thyroid gland—bipolar disorder	0.00252	0.00575	CbGeAlD
Vandetanib—LCK—thyroid gland—bipolar disorder	0.00252	0.00575	CbGeAlD
Vandetanib—AXL—thyroid gland—bipolar disorder	0.00251	0.00573	CbGeAlD
Vandetanib—FLT3—cerebellum—bipolar disorder	0.00249	0.00568	CbGeAlD
Vandetanib—STK35—cerebellum—bipolar disorder	0.00244	0.00556	CbGeAlD
Vandetanib—FMO3—thyroid gland—bipolar disorder	0.00244	0.00555	CbGeAlD
Vandetanib—SLK—thyroid gland—bipolar disorder	0.00242	0.00551	CbGeAlD
Vandetanib—EPHA5—brain—bipolar disorder	0.00238	0.00542	CbGeAlD
Vandetanib—TYRO3—brain—bipolar disorder	0.00238	0.00542	CbGeAlD
Vandetanib—ABL2—cerebellum—bipolar disorder	0.00238	0.00542	CbGeAlD
Vandetanib—FMO1—nervous system—bipolar disorder	0.00237	0.0054	CbGeAlD
Vandetanib—LYN—brain—bipolar disorder	0.00237	0.00539	CbGeAlD
Vandetanib—FYN—thyroid gland—bipolar disorder	0.00235	0.00536	CbGeAlD
Vandetanib—IRAK4—nervous system—bipolar disorder	0.00233	0.00532	CbGeAlD
Vandetanib—PDGFRB—adrenal cortex—bipolar disorder	0.00233	0.00532	CbGeAlD
Vandetanib—BMPR1B—brain—bipolar disorder	0.00233	0.00531	CbGeAlD
Vandetanib—MAP3K19—brain—bipolar disorder	0.00233	0.00531	CbGeAlD
Vandetanib—EGFR—cerebellum—bipolar disorder	0.00232	0.00529	CbGeAlD
Vandetanib—MAP4K5—thyroid gland—bipolar disorder	0.0023	0.00524	CbGeAlD
Vandetanib—TEK—thyroid gland—bipolar disorder	0.0023	0.00524	CbGeAlD
Vandetanib—ERBB3—nervous system—bipolar disorder	0.00229	0.00521	CbGeAlD
Vandetanib—RIPK2—cerebellum—bipolar disorder	0.00225	0.00513	CbGeAlD
Vandetanib—VEGFA—cerebellum—bipolar disorder	0.00224	0.00511	CbGeAlD
Vandetanib—IRAK4—cerebellum—bipolar disorder	0.0022	0.00501	CbGeAlD
Vandetanib—EPHB6—thyroid gland—bipolar disorder	0.0022	0.00501	CbGeAlD
Vandetanib—ERBB3—cerebellum—bipolar disorder	0.00215	0.00491	CbGeAlD
Vandetanib—MKNK1—nervous system—bipolar disorder	0.00215	0.0049	CbGeAlD
Vandetanib—YES1—thyroid gland—bipolar disorder	0.00212	0.00484	CbGeAlD
Vandetanib—RET—nervous system—bipolar disorder	0.00212	0.00484	CbGeAlD
Vandetanib—FGR—nervous system—bipolar disorder	0.00212	0.00484	CbGeAlD
Vandetanib—AXL—nervous system—bipolar disorder	0.00211	0.00482	CbGeAlD
Vandetanib—STK10—thyroid gland—bipolar disorder	0.0021	0.00479	CbGeAlD
Vandetanib—ABL1—adrenal cortex—bipolar disorder	0.00208	0.00474	CbGeAlD
Vandetanib—FMO3—nervous system—bipolar disorder	0.00205	0.00467	CbGeAlD
Vandetanib—SRC—thyroid gland—bipolar disorder	0.00204	0.00465	CbGeAlD
Vandetanib—MKNK1—cerebellum—bipolar disorder	0.00202	0.00461	CbGeAlD
Vandetanib—RET—cerebellum—bipolar disorder	0.002	0.00455	CbGeAlD
Vandetanib—AXL—cerebellum—bipolar disorder	0.00199	0.00453	CbGeAlD
Vandetanib—STK35—brain—bipolar disorder	0.00198	0.00452	CbGeAlD
Vandetanib—FYN—nervous system—bipolar disorder	0.00198	0.00451	CbGeAlD
Vandetanib—TEK—nervous system—bipolar disorder	0.00193	0.00441	CbGeAlD
Vandetanib—MAP4K5—nervous system—bipolar disorder	0.00193	0.00441	CbGeAlD
Vandetanib—ABL2—brain—bipolar disorder	0.00193	0.0044	CbGeAlD
Vandetanib—SLK—cerebellum—bipolar disorder	0.00191	0.00436	CbGeAlD
Vandetanib—EGFR—brain—bipolar disorder	0.00189	0.0043	CbGeAlD
Vandetanib—MAP2K5—thyroid gland—bipolar disorder	0.00188	0.00428	CbGeAlD
Vandetanib—KDR—thyroid gland—bipolar disorder	0.00188	0.00428	CbGeAlD
Vandetanib—FYN—cerebellum—bipolar disorder	0.00186	0.00424	CbGeAlD
Vandetanib—EPHB6—nervous system—bipolar disorder	0.00185	0.00421	CbGeAlD
Vandetanib—FLT4—brain—bipolar disorder	0.00184	0.00419	CbGeAlD
Vandetanib—RIPK2—brain—bipolar disorder	0.00183	0.00416	CbGeAlD
Vandetanib—VEGFA—brain—bipolar disorder	0.00182	0.00415	CbGeAlD
Vandetanib—TEK—cerebellum—bipolar disorder	0.00182	0.00415	CbGeAlD
Vandetanib—MAP4K5—cerebellum—bipolar disorder	0.00182	0.00415	CbGeAlD
Vandetanib—FMO1—brain—bipolar disorder	0.00181	0.00413	CbGeAlD
Vandetanib—CYP3A4—blood plasma—bipolar disorder	0.0018	0.0041	CbGeAlD
Vandetanib—YES1—nervous system—bipolar disorder	0.00179	0.00407	CbGeAlD
Vandetanib—IRAK4—brain—bipolar disorder	0.00178	0.00407	CbGeAlD
Vandetanib—STK10—nervous system—bipolar disorder	0.00177	0.00403	CbGeAlD
Vandetanib—ERBB3—brain—bipolar disorder	0.00175	0.00399	CbGeAlD
Vandetanib—EPHB6—cerebellum—bipolar disorder	0.00174	0.00396	CbGeAlD
Vandetanib—SRC—nervous system—bipolar disorder	0.00172	0.00391	CbGeAlD
Vandetanib—YES1—cerebellum—bipolar disorder	0.00168	0.00383	CbGeAlD
Vandetanib—STK10—cerebellum—bipolar disorder	0.00167	0.00379	CbGeAlD
Vandetanib—MKNK1—brain—bipolar disorder	0.00164	0.00374	CbGeAlD
Vandetanib—PDGFRB—thyroid gland—bipolar disorder	0.00163	0.00371	CbGeAlD
Vandetanib—FGR—brain—bipolar disorder	0.00162	0.0037	CbGeAlD
Vandetanib—RET—brain—bipolar disorder	0.00162	0.0037	CbGeAlD
Vandetanib—SRC—cerebellum—bipolar disorder	0.00162	0.00368	CbGeAlD
Vandetanib—AXL—brain—bipolar disorder	0.00162	0.00368	CbGeAlD
Vandetanib—ABCC1—adrenal cortex—bipolar disorder	0.00158	0.00361	CbGeAlD
Vandetanib—KDR—nervous system—bipolar disorder	0.00158	0.0036	CbGeAlD
Vandetanib—MAP2K5—nervous system—bipolar disorder	0.00158	0.0036	CbGeAlD
Vandetanib—FMO3—brain—bipolar disorder	0.00157	0.00357	CbGeAlD
Vandetanib—SLK—brain—bipolar disorder	0.00156	0.00354	CbGeAlD
Vandetanib—FYN—brain—bipolar disorder	0.00151	0.00345	CbGeAlD
Vandetanib—MAP2K5—cerebellum—bipolar disorder	0.00149	0.00339	CbGeAlD
Vandetanib—KDR—cerebellum—bipolar disorder	0.00149	0.00339	CbGeAlD
Vandetanib—TEK—brain—bipolar disorder	0.00148	0.00337	CbGeAlD
Vandetanib—MAP4K5—brain—bipolar disorder	0.00148	0.00337	CbGeAlD
Vandetanib—ABL1—thyroid gland—bipolar disorder	0.00145	0.0033	CbGeAlD
Vandetanib—EPHB6—brain—bipolar disorder	0.00141	0.00322	CbGeAlD
Vandetanib—PDGFRB—nervous system—bipolar disorder	0.00137	0.00312	CbGeAlD
Vandetanib—YES1—brain—bipolar disorder	0.00136	0.00311	CbGeAlD
Vandetanib—STK10—brain—bipolar disorder	0.00135	0.00308	CbGeAlD
Vandetanib—SRC—brain—bipolar disorder	0.00131	0.00299	CbGeAlD
Vandetanib—ABCG2—adrenal cortex—bipolar disorder	0.00131	0.00299	CbGeAlD
Vandetanib—PDGFRB—cerebellum—bipolar disorder	0.00129	0.00293	CbGeAlD
Vandetanib—ORM1—nervous system—bipolar disorder	0.00128	0.00292	CbGeAlD
Vandetanib—ABL1—nervous system—bipolar disorder	0.00122	0.00278	CbGeAlD
Vandetanib—MAP2K5—brain—bipolar disorder	0.00121	0.00275	CbGeAlD
Vandetanib—KDR—brain—bipolar disorder	0.00121	0.00275	CbGeAlD
Vandetanib—ABL1—cerebellum—bipolar disorder	0.00115	0.00261	CbGeAlD
Vandetanib—ABCC1—thyroid gland—bipolar disorder	0.0011	0.00252	CbGeAlD
Vandetanib—PDGFRB—brain—bipolar disorder	0.00105	0.00238	CbGeAlD
Vandetanib—ABL1—brain—bipolar disorder	0.000932	0.00212	CbGeAlD
Vandetanib—ABCG2—thyroid gland—bipolar disorder	0.000914	0.00208	CbGeAlD
Vandetanib—ABCC1—cerebellum—bipolar disorder	0.000874	0.00199	CbGeAlD
Vandetanib—ALB—brain—bipolar disorder	0.00086	0.00196	CbGeAlD
Vandetanib—ABCG2—cerebellum—bipolar disorder	0.000723	0.00165	CbGeAlD
Vandetanib—ABCC1—brain—bipolar disorder	0.00071	0.00162	CbGeAlD
Vandetanib—ABCG2—brain—bipolar disorder	0.000588	0.00134	CbGeAlD
Vandetanib—CYP3A4—nervous system—bipolar disorder	0.000535	0.00122	CbGeAlD
Vandetanib—LCK—Disease—ADCY2—bipolar disorder	3.9e-05	6.94e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HTR1A—bipolar disorder	3.89e-05	6.94e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—S100B—bipolar disorder	3.89e-05	6.93e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—GSK3B—bipolar disorder	3.88e-05	6.92e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—TCF7L2—bipolar disorder	3.88e-05	6.92e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TSHB—bipolar disorder	3.86e-05	6.87e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PDE4B—bipolar disorder	3.86e-05	6.87e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TACR1—bipolar disorder	3.86e-05	6.87e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—GSK3B—bipolar disorder	3.85e-05	6.86e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—DRD1—bipolar disorder	3.84e-05	6.84e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—HTR2C—bipolar disorder	3.84e-05	6.84e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TAC1—bipolar disorder	3.83e-05	6.83e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HTR1A—bipolar disorder	3.83e-05	6.83e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—S100B—bipolar disorder	3.81e-05	6.79e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TAC1—bipolar disorder	3.77e-05	6.73e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HTR2C—bipolar disorder	3.76e-05	6.7e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—DRD1—bipolar disorder	3.76e-05	6.7e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—GSK3A—bipolar disorder	3.76e-05	6.69e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NTRK2—bipolar disorder	3.74e-05	6.66e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—ADCY2—bipolar disorder	3.73e-05	6.66e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NRG1—bipolar disorder	3.73e-05	6.65e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—DRD3—bipolar disorder	3.72e-05	6.63e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—GSK3A—bipolar disorder	3.7e-05	6.6e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—DRD1—bipolar disorder	3.7e-05	6.6e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HTR2C—bipolar disorder	3.7e-05	6.6e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—S100B—bipolar disorder	3.67e-05	6.55e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TRPC3—bipolar disorder	3.67e-05	6.54e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL1B—bipolar disorder	3.66e-05	6.53e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NTRK2—bipolar disorder	3.66e-05	6.52e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—HTR2A—bipolar disorder	3.66e-05	6.51e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—DRD3—bipolar disorder	3.64e-05	6.49e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—GSK3A—bipolar disorder	3.63e-05	6.46e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—DRD4—bipolar disorder	3.61e-05	6.43e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NTRK2—bipolar disorder	3.6e-05	6.42e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—NRG1—bipolar disorder	3.6e-05	6.41e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ADCY2—bipolar disorder	3.59e-05	6.4e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—DRD3—bipolar disorder	3.59e-05	6.39e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—GSK3B—bipolar disorder	3.58e-05	6.38e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—SNAP25—bipolar disorder	3.57e-05	6.36e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—GSK3A—bipolar disorder	3.57e-05	6.36e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—HTR2A—bipolar disorder	3.56e-05	6.35e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NRG1—bipolar disorder	3.55e-05	6.33e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—DRD4—bipolar disorder	3.54e-05	6.3e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL1B—bipolar disorder	3.52e-05	6.28e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—HTR2A—bipolar disorder	3.52e-05	6.28e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL1B—bipolar disorder	3.51e-05	6.26e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ADM—bipolar disorder	3.5e-05	6.24e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—DRD4—bipolar disorder	3.48e-05	6.2e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—ADCY2—bipolar disorder	3.45e-05	6.14e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—GSK3B—bipolar disorder	3.44e-05	6.12e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—TCF7L2—bipolar disorder	3.44e-05	6.12e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NRG1—bipolar disorder	3.43e-05	6.11e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PDE4B—bipolar disorder	3.41e-05	6.08e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TSHB—bipolar disorder	3.41e-05	6.08e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TACR1—bipolar disorder	3.41e-05	6.08e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—POMC—bipolar disorder	3.41e-05	6.07e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—ADCY2—bipolar disorder	3.4e-05	6.06e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TCF7L2—bipolar disorder	3.39e-05	6.04e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NRG1—bipolar disorder	3.37e-05	6e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—DRD2—bipolar disorder	3.36e-05	5.99e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—MTHFR—bipolar disorder	3.36e-05	5.99e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—ADCY2—bipolar disorder	3.33e-05	5.93e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—HTR2A—bipolar disorder	3.32e-05	5.92e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TCF7L2—bipolar disorder	3.32e-05	5.91e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HTR1A—bipolar disorder	3.31e-05	5.9e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NRG1—bipolar disorder	3.3e-05	5.87e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—DRD2—bipolar disorder	3.29e-05	5.87e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—ADCY2—bipolar disorder	3.28e-05	5.84e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TCF7L2—bipolar disorder	3.26e-05	5.82e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TAC1—bipolar disorder	3.26e-05	5.81e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—S100B—bipolar disorder	3.25e-05	5.8e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—NRG1—bipolar disorder	3.24e-05	5.78e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—DRD2—bipolar disorder	3.24e-05	5.78e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—MTHFR—bipolar disorder	3.24e-05	5.77e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL1B—bipolar disorder	3.23e-05	5.76e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—GSK3B—bipolar disorder	3.22e-05	5.73e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—HTR2A—bipolar disorder	3.2e-05	5.71e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HTR2C—bipolar disorder	3.2e-05	5.7e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—DRD1—bipolar disorder	3.2e-05	5.7e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—POMC—bipolar disorder	3.19e-05	5.69e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HTR1A—bipolar disorder	3.19e-05	5.69e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—INS—bipolar disorder	3.17e-05	5.66e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ADCY2—bipolar disorder	3.16e-05	5.63e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TAC1—bipolar disorder	3.14e-05	5.6e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NTRK2—bipolar disorder	3.11e-05	5.54e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—NRG1—bipolar disorder	3.11e-05	5.54e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—DRD3—bipolar disorder	3.1e-05	5.52e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—HTR2A—bipolar disorder	3.09e-05	5.51e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—GSK3A—bipolar disorder	3.08e-05	5.5e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—DRD1—bipolar disorder	3.08e-05	5.49e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HTR2C—bipolar disorder	3.08e-05	5.49e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—COMT—bipolar disorder	3.08e-05	5.48e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—MAOA—bipolar disorder	3.05e-05	5.44e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—IMPA1—bipolar disorder	3.05e-05	5.43e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	3.05e-05	5.43e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—DRD4—bipolar disorder	3.01e-05	5.36e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NTRK2—bipolar disorder	3e-05	5.34e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—NRG1—bipolar disorder	2.99e-05	5.34e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—DRD3—bipolar disorder	2.98e-05	5.32e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NTRK1—bipolar disorder	2.98e-05	5.31e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—GSK3A—bipolar disorder	2.97e-05	5.3e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MTHFR—bipolar disorder	2.97e-05	5.29e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	2.96e-05	5.28e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	2.94e-05	5.25e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NTRK1—bipolar disorder	2.94e-05	5.23e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—GSK3B—bipolar disorder	2.93e-05	5.23e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	2.92e-05	5.2e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—INS—bipolar disorder	2.9e-05	5.17e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—S100B—bipolar disorder	2.9e-05	5.17e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—DRD4—bipolar disorder	2.9e-05	5.16e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—GSK3B—bipolar disorder	2.87e-05	5.12e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—NRG1—bipolar disorder	2.87e-05	5.12e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—GSK3B—bipolar disorder	2.87e-05	5.11e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—GSK3B—bipolar disorder	2.86e-05	5.09e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—S100B—bipolar disorder	2.85e-05	5.08e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—POMC—bipolar disorder	2.85e-05	5.07e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—GSK3B—bipolar disorder	2.84e-05	5.06e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL1B—bipolar disorder	2.84e-05	5.05e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ADCY2—bipolar disorder	2.83e-05	5.04e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—INS—bipolar disorder	2.83e-05	5.04e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CLOCK—bipolar disorder	2.83e-05	5.04e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—GSK3B—bipolar disorder	2.83e-05	5.04e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR1A—bipolar disorder	2.83e-05	5.03e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TCF7L2—bipolar disorder	2.82e-05	5.03e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—POMC—bipolar disorder	2.81e-05	5.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—DRD2—bipolar disorder	2.8e-05	4.99e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—INS—bipolar disorder	2.8e-05	4.99e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—MTHFR—bipolar disorder	2.8e-05	4.99e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TAC1—bipolar disorder	2.78e-05	4.96e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TPH2—bipolar disorder	2.76e-05	4.91e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TSHB—bipolar disorder	2.76e-05	4.91e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CACNB2—bipolar disorder	2.76e-05	4.91e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD1—bipolar disorder	2.73e-05	4.86e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR2C—bipolar disorder	2.73e-05	4.86e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ADCY2—bipolar disorder	2.73e-05	4.86e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	2.72e-05	4.84e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—DPYD—bipolar disorder	2.71e-05	4.83e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—GSK3B—bipolar disorder	2.71e-05	4.83e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—COMT—bipolar disorder	2.71e-05	4.82e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—DRD2—bipolar disorder	2.7e-05	4.81e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—MTHFR—bipolar disorder	2.7e-05	4.8e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—MAOA—bipolar disorder	2.69e-05	4.79e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—INS—bipolar disorder	2.67e-05	4.76e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NTRK2—bipolar disorder	2.65e-05	4.73e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—POMC—bipolar disorder	2.65e-05	4.73e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—NRG1—bipolar disorder	2.65e-05	4.72e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD3—bipolar disorder	2.64e-05	4.71e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—GSK3A—bipolar disorder	2.63e-05	4.69e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	2.61e-05	4.66e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—GSK3B—bipolar disorder	2.61e-05	4.65e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.59e-05	4.62e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—GSK3B—bipolar disorder	2.58e-05	4.59e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—INS—bipolar disorder	2.58e-05	4.59e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD4—bipolar disorder	2.57e-05	4.57e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NRG1—bipolar disorder	2.56e-05	4.56e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—POMC—bipolar disorder	2.56e-05	4.56e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—INS—bipolar disorder	2.54e-05	4.53e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NTRK1—bipolar disorder	2.54e-05	4.52e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CACNA1C—bipolar disorder	2.52e-05	4.49e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NRG1—bipolar disorder	2.52e-05	4.49e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.51e-05	4.47e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—GSK3B—bipolar disorder	2.49e-05	4.44e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—MTHFR—bipolar disorder	2.49e-05	4.43e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—POMC—bipolar disorder	2.47e-05	4.4e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—S100B—bipolar disorder	2.47e-05	4.39e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—INS—bipolar disorder	2.46e-05	4.38e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3C2A—bipolar disorder	2.46e-05	4.38e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NTRK1—bipolar disorder	2.44e-05	4.36e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—GSK3B—bipolar disorder	2.44e-05	4.35e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.42e-05	4.32e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ADCY2—bipolar disorder	2.41e-05	4.3e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TCF7L2—bipolar disorder	2.41e-05	4.29e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—GSK3B—bipolar disorder	2.39e-05	4.26e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD2—bipolar disorder	2.39e-05	4.26e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—MTHFR—bipolar disorder	2.39e-05	4.25e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—S100B—bipolar disorder	2.38e-05	4.23e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—INS—bipolar disorder	2.36e-05	4.21e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	2.36e-05	4.2e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—GSK3B—bipolar disorder	2.35e-05	4.2e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HTR2A—bipolar disorder	2.31e-05	4.11e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HTR2A—bipolar disorder	2.27e-05	4.05e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—GSK3B—bipolar disorder	2.26e-05	4.02e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NR1D1—bipolar disorder	2.25e-05	4.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—INS—bipolar disorder	2.23e-05	3.96e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SNAP25—bipolar disorder	2.2e-05	3.93e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—MTHFR—bipolar disorder	2.19e-05	3.9e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NRG1—bipolar disorder	2.18e-05	3.88e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—GSK3B—bipolar disorder	2.17e-05	3.87e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NTRK1—bipolar disorder	2.16e-05	3.86e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—bipolar disorder	2.16e-05	3.85e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NCAN—bipolar disorder	2.16e-05	3.84e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—INS—bipolar disorder	2.14e-05	3.82e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—bipolar disorder	2.11e-05	3.77e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	2.11e-05	3.76e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—bipolar disorder	2.1e-05	3.75e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—S100B—bipolar disorder	2.1e-05	3.75e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NRG1—bipolar disorder	2.1e-05	3.74e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—GSK3B—bipolar disorder	2.08e-05	3.71e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—bipolar disorder	2.08e-05	3.71e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—POMC—bipolar disorder	1.99e-05	3.54e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—INS—bipolar disorder	1.98e-05	3.52e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HTR2A—bipolar disorder	1.96e-05	3.5e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ADCY2—bipolar disorder	1.95e-05	3.47e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—GSK3B—bipolar disorder	1.92e-05	3.43e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—INS—bipolar disorder	1.9e-05	3.38e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	1.9e-05	3.38e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HTR2A—bipolar disorder	1.89e-05	3.37e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	1.88e-05	3.35e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—INS—bipolar disorder	1.87e-05	3.33e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—GSK3B—bipolar disorder	1.86e-05	3.31e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NRG1—bipolar disorder	1.86e-05	3.31e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—POMC—bipolar disorder	1.84e-05	3.28e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—INS—bipolar disorder	1.83e-05	3.26e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—GSK3B—bipolar disorder	1.83e-05	3.26e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—bipolar disorder	1.81e-05	3.23e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—INS—bipolar disorder	1.8e-05	3.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—bipolar disorder	1.8e-05	3.2e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—bipolar disorder	1.75e-05	3.12e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—INS—bipolar disorder	1.74e-05	3.1e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—bipolar disorder	1.73e-05	3.09e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR2A—bipolar disorder	1.67e-05	2.98e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—COMT—bipolar disorder	1.67e-05	2.98e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MAOA—bipolar disorder	1.66e-05	2.95e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—GSK3B—bipolar disorder	1.58e-05	2.81e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—bipolar disorder	1.57e-05	2.79e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—INS—bipolar disorder	1.56e-05	2.78e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—bipolar disorder	1.53e-05	2.73e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.53e-05	2.72e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—GSK3B—bipolar disorder	1.52e-05	2.71e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—bipolar disorder	1.51e-05	2.69e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—INS—bipolar disorder	1.5e-05	2.68e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TPH2—bipolar disorder	1.49e-05	2.65e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TSHB—bipolar disorder	1.49e-05	2.65e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.49e-05	2.65e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DPYD—bipolar disorder	1.46e-05	2.61e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.36e-05	2.42e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTHFR—bipolar disorder	1.35e-05	2.41e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—GSK3B—bipolar disorder	1.35e-05	2.4e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—bipolar disorder	1.34e-05	2.38e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—INS—bipolar disorder	1.33e-05	2.37e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.33e-05	2.36e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.19e-05	2.12e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—bipolar disorder	1.08e-05	1.92e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—INS—bipolar disorder	1.07e-05	1.91e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.05e-05	1.88e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—COMT—bipolar disorder	9.01e-06	1.61e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MAOA—bipolar disorder	8.95e-06	1.59e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTHFR—bipolar disorder	7.29e-06	1.3e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—bipolar disorder	5.83e-06	1.04e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—INS—bipolar disorder	5.79e-06	1.03e-05	CbGpPWpGaD
